FDA Approves FUROSEMIDE — Marlex Pharmaceuticals, Inc.
The FDA has confirmed the approval of Marlex Pharmaceuticals' oral furosemide product, supporting a staple in acute treatment protocols. While not a novel molecule, broadening the commercial availability creates a competitive ripple effect in the generic diuretic space.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day